Profile data is unavailable for this security.
About the company
Molecular Partners AG is a Switzerland-based clinical-stage biotech company developing DARPin (Designed Ankyrin Repeat Proteins) a new class of custom-built protein therapeutics based on natural binding proteins that open a new dimension of multi-functionality and multi-target specificity in drug design. The Company has formed partnerships with leading pharmaceutical companies to advance DARPin therapeutics , and has compounds in various stages of clinical and preclinical development across multiple therapeutic areas.
- Revenue in USD (TTM)0.00
- Net income in USD-78.49m
- Incorporated2004
- Employees153.00
- LocationMolecular Partners AGWagistrasse 14SCHLIEREN 8952SwitzerlandCHE
- Phone+41 447557700
- Fax+41 447557707
- Websitehttps://www.molecularpartners.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sagimet Biosciences Inc | 0.00 | -57.67m | 164.56m | 14.00 | -- | 1.38 | -- | -- | -1.79 | -1.79 | 0.00 | 3.67 | 0.00 | -- | -- | 0.00 | -38.04 | -40.69 | -39.78 | -43.01 | -- | -- | -- | -6,987.70 | -- | -- | 0.00 | -- | -100.00 | -- | -63.46 | -- | -- | -- |
| MDxHealth SA | 103.07m | -31.43m | 168.29m | 312.00 | -- | -- | -- | 1.63 | -0.7275 | -0.7275 | 2.21 | -0.1669 | 0.6614 | 7.00 | 6.20 | 330,349.30 | -20.17 | -40.27 | -29.24 | -50.75 | 64.48 | 57.38 | -30.50 | -76.84 | 1.02 | -0.8112 | 1.10 | -- | 28.29 | 50.19 | 11.67 | -- | 96.87 | -- |
| Tharimmune Inc | 0.00 | -10.32m | 169.03m | 2.00 | -- | 5.25 | -- | -- | -4.11 | -4.11 | 0.00 | 0.854 | 0.00 | -- | -- | 0.00 | -159.36 | -169.40 | -225.01 | -410.04 | -- | -- | -- | -- | -- | -- | 0.0255 | -- | -- | -- | -30.89 | -- | -- | -- |
| Cartesian Therapeutics Inc | 1.93m | -50.61m | 169.54m | 66.00 | -- | -- | -- | 87.98 | -1.97 | -1.97 | 0.0743 | -1.38 | 0.0047 | -- | 0.6943 | 29,196.97 | -11.59 | -33.50 | -12.10 | -45.25 | -- | -- | -2,489.83 | -128.46 | -- | -- | -- | -- | 49.64 | 42.27 | 69.90 | -- | 186.63 | -- |
| Editas Medicine Inc | 46.38m | -199.84m | 171.81m | 246.00 | -- | 12.20 | -- | 3.70 | -2.38 | -2.38 | 0.5454 | 0.1443 | 0.1753 | -- | 11.24 | 188,548.80 | -75.51 | -34.19 | -101.13 | -38.43 | -- | -- | -430.84 | -373.02 | -- | -- | 0.8145 | -- | -58.64 | 9.50 | -54.74 | -- | 7.43 | -- |
| Zentalis Pharmaceuticals Inc | 26.87m | -149.32m | 172.68m | 166.00 | -- | 0.6828 | -- | 6.43 | -2.08 | -2.08 | 0.3743 | 3.50 | 0.0691 | -- | -- | 161,837.30 | -38.39 | -43.59 | -43.54 | -49.56 | -- | -- | -555.80 | -1,402.74 | -- | -- | 0.00 | -- | -- | -- | 43.24 | -- | -8.89 | -- |
| Tiziana Life Sciences Ltd - ADR | 0.00 | -12.84m | 174.99m | 8.00 | -- | 17.95 | -- | -- | -0.1136 | -0.1136 | 0.00 | 0.0774 | 0.00 | -- | -- | 0.00 | -93.18 | -57.21 | -231.54 | -73.22 | -- | -- | -- | -- | -- | -- | 0.0115 | -- | -- | -- | 32.94 | -- | 37.77 | -- |
| Galectin Therapeutics Inc | 0.00 | -37.44m | 177.94m | 15.00 | -- | -- | -- | -- | -0.5913 | -0.5913 | 0.00 | -1.92 | 0.00 | -- | -- | 0.00 | -178.33 | -117.54 | -- | -197.34 | -- | -- | -- | -- | -- | -3.57 | -- | -- | -- | -- | -5.35 | -- | -- | -- |
| Molecular Partners AG (ADR) | 0.00 | -78.49m | 179.03m | 153.00 | -- | 1.38 | -- | -- | -2.13 | -2.13 | 0.00 | 3.33 | 0.00 | -- | -- | 0.00 | -45.23 | -13.09 | -49.34 | -15.66 | -- | 99.25 | -- | -56.51 | -- | -- | 0.0158 | -- | -29.38 | -24.59 | 12.81 | -- | -17.26 | -- |
| C4 Therapeutics Inc | 30.11m | -119.08m | 183.17m | 110.00 | -- | 0.9079 | -- | 6.08 | -1.67 | -1.67 | 0.4225 | 2.08 | 0.0939 | -- | 3.57 | 273,709.10 | -37.12 | -26.50 | -42.35 | -29.90 | -- | -- | -395.51 | -310.19 | -- | -- | 0.00 | -- | 71.44 | 10.72 | 20.51 | -- | -33.16 | -- |
| SAB Biotherapeutics Inc | 114.70k | -21.37m | 183.29m | 63.00 | -- | 1.11 | 8.34 | 1,597.96 | -2.81 | -2.81 | 0.0043 | 3.48 | 0.001 | -- | 0.3492 | 1,820.64 | 15.80 | -- | 17.22 | -- | -- | -- | 16,338.04 | -- | -- | -- | 0.0197 | -- | -40.94 | -- | 19.17 | -- | -- | -- |
| Insight Molecular Diagnostics Inc | 4.40m | -60.78m | 184.65m | 46.00 | -- | -- | -- | 41.95 | -2.83 | -2.83 | 0.1643 | -0.3213 | 0.0771 | 5.67 | 18.85 | 95,695.65 | -106.49 | -41.57 | -124.80 | -46.86 | 54.73 | 24.70 | -1,380.69 | -2,290.77 | 2.73 | -171.82 | -- | -- | 25.15 | -- | -136.17 | -- | -10.88 | -- |
| Ovid Therapeutics Inc | 6.61m | -36.33m | 184.86m | 23.00 | -- | 2.26 | -- | 27.97 | -0.5112 | -0.5112 | 0.093 | 0.6282 | 0.0794 | -- | -- | 287,391.30 | -43.64 | -13.89 | -49.07 | -15.44 | -- | -- | -549.62 | -40.79 | -- | -- | 0.00 | -- | 44.50 | -- | 49.50 | -- | -7.98 | -- |
| Sol Gel Technologies Ltd | 18.97m | -8.99m | 187.20m | 34.00 | -- | 7.19 | -- | 9.87 | -3.23 | -3.23 | 6.81 | 9.34 | 0.4891 | -- | 2.25 | 557,941.20 | -23.17 | -29.32 | -27.70 | -33.19 | -- | -- | -47.37 | -138.22 | -- | -- | 0.00 | -- | 642.47 | -12.81 | 61.16 | -- | -68.01 | -- |
| Voyager Therapeutics Inc | 31.32m | -126.78m | 188.48m | 172.00 | -- | 0.8556 | -- | 6.02 | -2.17 | -2.17 | 0.5358 | 3.96 | 0.0877 | -- | 2.64 | 182,069.80 | -35.50 | -1.01 | -39.95 | -1.27 | -- | -- | -404.85 | -2.34 | -- | -- | 0.00 | -- | -68.00 | -5.18 | -149.12 | -- | -14.53 | -- |
Data as of Feb 13 2026. Currency figures normalised to Molecular Partners AG's reporting currency: US Dollar USD
8.89%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Suvretta Capital Management LLCas of 30 Sep 2025 | 2.22m | 5.50% |
| BVF Partners LPas of 30 Sep 2025 | 1.35m | 3.35% |
| SmartHarvest Portfolios LLCas of 31 Dec 2025 | 12.31k | 0.03% |
| Morgan Stanley & Co. LLCas of 31 Dec 2025 | 367.00 | 0.00% |
| UBS Securities LLCas of 31 Dec 2025 | 349.00 | 0.00% |
| Merrill Lynch, Pierce, Fenner & Smith, Inc. (Invt Mgmt)as of 30 Sep 2025 | 157.00 | 0.00% |
| EverSource Wealth Advisors LLCas of 31 Dec 2025 | 24.00 | 0.00% |
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
